A
ACHIEVE LIFE SCIENCES INC
NASDAQ: ACHV (Achieve Life Sciences, Inc.)
Kemas kini terakhir: 4 jam lalu6.83
-0.36 (-5.01%)
| Penutupan Terdahulu | 7.19 |
| Jumlah Dagangan | 1,376,391 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.35 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 96.90% |
| Nisbah Semasa (MRQ) | 3.51 |
| Aliran Tunai Operasi (OCF TTM) | -35.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.11 M |
| Pulangan Atas Aset (ROA TTM) | -59.02% |
| Pulangan Atas Ekuiti (ROE TTM) | -154.55% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Achieve Life Sciences, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -1.2 |
| Persekitaran Makro | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.97 |
|
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 9.69% |
| % Dimiliki oleh Institusi | 41.59% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Tpg Gp A, Llc | 30 Jun 2026 | 6,877,580 |
| Venbio Partners Llc | 30 Jun 2026 | 5,914,720 |
| Propel Bio Management, Llc | 30 Jun 2026 | 4,034,018 |
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |